in this two-phase study , 21 pediatric patients with epilepsy and spasticity were initially treated with dantrolene sodium suspension and , after a washout period , began a double-blind portion where one half received dantrolene sodium suspension and the other half received a placebo suspension .
C0026838
spasticity
C0010977
dantrolene sodium